Search

Author/Creator Liu Leage, Soyi

1. A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Issue 1 (28th September 2019)

Authors:
Mease, Philip J; Smolen, Josef S; Behrens, Frank; Nash, Peter; Liu Leage, Soyi; Li, Lingnan; Tahir, Hasan; Gooderham, Melinda; Krishnan, Eswar; Liu-Seifert, Hong; Emery, Paul; Pillai, Sreekumar G; Helliwell, Philip S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79:Issue 1(2020)
Page Start:
123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y). Issue 8 (6th May 2021)

Authors:
Landewé, Robert BM; Gensler, Lianne S; Poddubnyy, Denis; Rahman, Proton; Hojnik, Maja; Li, Xiaoqi; Liu Leage, Soyi; Adams, David; Carlier, Hilde; Van den Bosch, Filip
Other Names:
author non-byline.; Ariel Federico Javier author non-byline.; Berman Alberto author non-byline.; Carrio Judith author non-byline.; Lucero Eleonora Del Valle author non-byline.; Cocco Jose Maldonado author non-byline.; Velasco Benito Jorge author non-byline.; Resch Heinrich author non-byline.; Gr...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 80:Issue 8(2021)
Page Start:
1022
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. LB0005 MULTICENTRE, RANDOMISED, OPEN-LABEL, ASSESSOR-BLINDED, PARALLEL-GROUP HEAD-TO-HEAD COMPARISON OF THE EFFICACY AND SAFETY OF IXEKIZUMAB VERSUS ADALIMUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS NAIVE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: 24-WEEK RESULTS. (June 2019)

Authors:
Mease, Philip J.; S. Smolen, Josef; Behrens, Frank; Nash, Peter; Liu Leage, Soyi; Lingnan, LI; Tahir, Hasan; Gooderham, Melinda; Krishnan, Eswar; Emery, Paul; Pillai, Sreekumar; Helliwell, Philip
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
261
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52. Issue 10 (13th July 2020)

Authors:
Smolen, Josef S; Mease, Philip; Tahir, Hasan; Schulze-Koops, Hendrik; de la Torre, Inmaculada; Li, Lingnan; Hojnik, Maja; Sapin, Christophe; Okada, Masato; Caporali, Roberto; Gratacós, Jordi; Goupille, Philippe; Liu Leage, Soyi; Pillai, Sreekumar; Nash, Peter
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79:Issue 10(2020)
Page Start:
1310
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study. Issue 2 (13th September 2022)

Authors:
Landewé, Robert B M; Poddubnyy, Denis; Rahman, Proton; Van den Bosch, Filip E; Bolce, Rebecca; Liu Leage, Soyi; Lisse, Jeffrey R; Park, So Young; Gensler, Lianne
Journal:
Annals of the rheumatic diseases
Issue:
Volume 82:Issue 2(2023)
Page Start:
212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗